Feasibility of and associated cost savings from transitioning to therapeutic biosimilar use in a large community oncology network.

被引：0
|
作者：
Young, Garrett
McGee, Kathy
Owens, Leah
McCullough, Stacey
Arrowsmith, Edward
Poole, Stacey L.
Marsden, Mary Catherine
Lyss, Aaron J.
Schleicher, Stephen Matthew
Richey, Sylvia S.
Dickson, Natalie R.
Schwartzberg, Lee S.
机构：
[1] OneOncology, Nashville, TN USA
[2] Tennessee Oncol, Nashville, TN USA
[3] West Canc Ctr, Memphis, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 29期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9
引用
收藏
页数：2
相关论文
共 41 条
  • [1] The effect of guideline-concordant novel therapy use on meeting cost targets in OCM: Results from a large community oncology network.
    Schleicher, Stephen Matthew
    Chaudhry, Basit
    Waynick, Christopher A.
    Crouse, Cheryl A.
    Shipley, Johnathan D.
    Dickson, Natalie R.
    Patton, Jeffrey
    Supalla, Susanna N.
    Soudek, Daniel
    Lyss, Aaron J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Midlevel provider utilization within a large community oncology network.
    Mikan, Sabrina Q.
    Cody, Melinda Madison
    Lindsey, Lori
    Carter, Patricia
    Hoverman, J. Russell
    Patt, Debra A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [3] Therapeutic interchange: The cornerstone of cost effectiveness in the Oncology Care Model performance for the US Oncology Network.
    Ives, Hope
    Feinberg, Erica
    Indurlal, Puneeth
    Wilfong, Lalan S.
    Dominguez, Kaci
    Garey, Jody S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 5 - 5
  • [4] Cost Savings Associated With the Use of Community Health Centers
    Richard, Patrick
    Ku, Leighton
    Dor, Avi
    Tan, Ellen
    Shin, Peter
    Rosenbaum, Sara
    JOURNAL OF AMBULATORY CARE MANAGEMENT, 2012, 35 (01): : 50 - 59
  • [5] Use of antiemetic prophylaxis and oral breakthrough medication for highly emetogenic chemotherapy (HEC) in a large community oncology network.
    Young, Garrett
    Schleicher, Stephen Matthew
    Arrowsmith, Edward
    McCullough, Stacey
    Richey, Sylvia S.
    Blakely, Johnetta
    Dickson, Natalie R.
    Schwartzberg, Lee S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [6] Evaluation of real-world cost savings and utilization of biosimilar drugs in a community-based oncology practice
    Sanyal, Amit
    Schmitt, Michelle
    Wellner, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [7] Real-world patterns of chemotherapy and immunotherapy utilization at end of life in a large community oncology network.
    Schleicher, Stephen Matthew
    Young, Garrett
    Arrowsmith, Edward
    Prince, Cheryl A.
    Winters, Lynn Kay
    Lyss, Aaron J.
    Waynick, Christopher A.
    Mudumbi, Sandhya
    Allen, Duncan
    Dickson, Natalie R.
    Schwartzberg, Lee S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [8] Biosimilar uptake and cost savings analysis before and after implementation of a pharmacist-driven substitution program within a National Community Oncology Network: One-year follow-up
    Chang, Melody
    Li, Jenny
    Peters, Brooke
    Winegar, Bradley
    Carr, Robert
    Rodriguez, Camilo
    Kohler-Gerber, Ashley
    Connor, Darell
    Freeman, Taqyra
    Brown, Kyle
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Cost Savings from Assertive Community Treatment Services in an Era of Declining Psychiatric Inpatient Use
    Slade, Eric P.
    McCarthy, John F.
    Valenstein, Marcia
    Visnic, Stephanie
    Dixon, Lisa B.
    HEALTH SERVICES RESEARCH, 2013, 48 (01) : 195 - 217
  • [10] Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network.
    Neubauer, M. A.
    Garey, J. S.
    Nelson, G. C.
    Patt, D. A.
    Cartwright, T. H.
    Hoverman, J. R.
    Busby, L. T.
    Brooks, B. D.
    Sitarik, M. A.
    Kolodziej, M. A.
    Anderson, R. W.
    Beveridge, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345